Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 102

Results For "non"

1278 News Found

Experts point out key issues for vision loss at ASSOCHAM meet
Healthcare | February 24, 2022

Experts point out key issues for vision loss at ASSOCHAM meet

Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes


Taro to Acquire Alchemee from Galderma
Biotech | February 23, 2022

Taro to Acquire Alchemee from Galderma

Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care


Bayer highlights pharma business plans on Media Day
News | February 23, 2022

Bayer highlights pharma business plans on Media Day

Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)


Medtronic receives USFDA approval for InterStim X system to manage bladder and bowel control
Medical Device | February 23, 2022

Medtronic receives USFDA approval for InterStim X system to manage bladder and bowel control

New InterStim X system provides 10 to 15 years of battery life without the need to recharge


Biorchestra announces US$45 million series C fundraising
News | February 23, 2022

Biorchestra announces US$45 million series C fundraising

he financing was significantly oversubscribed with high demand from both existing and new investors.


Agilent posts Q1 FY2022 revenue at US$ 1.67 billion
News | February 23, 2022

Agilent posts Q1 FY2022 revenue at US$ 1.67 billion

Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.


Mental healthcare app heyy raises pre-seed funding
Startup | February 22, 2022

Mental healthcare app heyy raises pre-seed funding

US $ 555,000 invested by Wavemaker Partners in pre-seed round


Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s
Biotech | February 21, 2022

Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s

Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company


VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem
Supply Chain | February 21, 2022

VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem

By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem


Poxel’s PXL065 granted FDA fast track designation for X-linked adrenoleukodystrophy
Drug Approval | February 20, 2022

Poxel’s PXL065 granted FDA fast track designation for X-linked adrenoleukodystrophy

Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear